Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Cash Flow for Capital Expenditures
$-1,520 Mil (TTM As of Dec. 2013)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Teva Pharmaceutical Industries Ltd's cash flow for capital expenditures for the three months ended in Dec. 2013 was $-803 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2013 was $-1,520 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Teva Pharmaceutical Industries Ltd Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Dec. 2013 was -264 (Mar. 2013 ) + -225 (Jun. 2013 ) + -228 (Sep. 2013 ) + -803 (Dec. 2013 ) = $-1,520 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Cash Flow_CPEX -311-310-390-542-681-719-710-1,053-1,104-1,031

Teva Pharmaceutical Industries Ltd Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
Cash Flow_CPEX -276-317-274-254-249-855-264-225-228-803
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide